Logo image of BMRN

BIOMARIN PHARMACEUTICAL INC (BMRN) Stock Analyst Earnings Estimates

NASDAQ:BMRN - Nasdaq - US09061G1013 - Common Stock - Currency: USD

71.16  +2.04 (+2.95%)

After market: 71.16 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
BMRN revenue by date.BMRN revenue by date.
2.096B
13.52%
2.419B
15.42%
2.854B
17.97%
3.167B
10.97%
3.49B
10.20%
3.65B
4.58%
3.916B
7.29%
4.049B
3.40%
4.22B
4.22%
4.148B
-1.71%
4.26B
2.70%
EBITDA
YoY % growth
BMRN ebitda by date.BMRN ebitda by date.
166.6M
588.43%
290.16M
74.17%
666.468M
129.69%
864.82M
29.76%
1.118B
29.28%
1.167B
4.38%
1.33B
13.97%
1.475B
10.90%
1.622B
9.97%
1.698B
4.69%
1.713B
0.88%
EBIT
YoY % growth
BMRN ebit by date.BMRN ebit by date.
64.6M
177.09%
185.774M
187.58%
570.042M
206.85%
746.69M
30.99%
1.007B
34.86%
1.144B
13.60%
1.289B
12.67%
1.431B
11.02%
1.54B
7.62%
1.481B
-3.83%
1.5B
1.28%
Operating Margin
BMRN operating margin by date.BMRN operating margin by date.
3.08%7.68%19.97%23.58%28.85%31.34%32.92%35.34%36.49%35.70%35.21%
EPS
YoY % growth
BMRN eps by date.BMRN eps by date.
0.29
180.56%
0.95
227.59%
2.21
132.63%
3.10
40.10%
4.07
31.38%
5.69
39.98%
6.82
19.77%
7.43
8.98%
7.71
3.67%
7.38
-4.26%
7.83
6.10%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.71
54.12%
0.77
38.33%
0.80
46.16%
0.93
45.24%
0.77
8.08%
0.78
0.90%
0.82
2.36%
0.93
0.29%
Revenue
Q2Q % growth
757.24M
16.71%
783.52M
10.04%
810.41M
8.67%
846.37M
13.26%
832.34M
9.92%
847.9M
8.22%
872.01M
7.60%
904.87M
6.91%
EBITDA
Q2Q % growth
170.67M
61.30%
182.49M
-14.44%
193.27M
-16.06%
244.15M
-8.79%
N/AN/AN/AN/A
EBIT
Q2Q % growth
163.26M
108.08%
181.23M
13.64%
193.42M
22.87%
226.2M
32.09%
218.21M
33.66%
224.36M
23.80%
241.04M
24.62%
295.26M
30.53%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
0.64
255.56%
0.540.1018.42%
Q3 2024
Q2Q % growth
0.55
161.90%
0.530.024.22%
Q2 2024
Q2Q % growth
0.56
93.10%
0.360.2057.23%
Q1 2024
Q2Q % growth
0.46
70.37%
0.350.1130.72%
Q4 2023
Q2Q % growth
0.18 0.24-0.06-24.46%
Q3 2023
Q2Q % growth
0.21
625.00%
0.24-0.03-12.05%
Q2 2023
Q2Q % growth
0.29
93.33%
0.240.0522.09%
Q1 2023
Q2Q % growth
0.27
50.00%
0.180.0947.54%
Q4 2022
Q2Q % growth
0.00
100.00%
-0.070.07100.00%
Q3 2022
Q2Q % growth
-0.04
80.00%
-0.01-0.03-361.36%
Q2 2022
Q2Q % growth
0.15
114.29%
0.120.0329.99%
Q1 2022
Q2Q % growth
0.18
100.00%
0.180.002.52%
Q4 2021
Q2Q % growth
-0.32
-366.67%
-0.330.012.37%
Q3 2021
Q2Q % growth
-0.20
-104.99%
-0.250.0520.94%
Q2 2021
Q2Q % growth
0.07
450.00%
-0.120.19158.23%
Q1 2021
Q2Q % growth
0.09
-79.55%
-0.070.16231.05%
Q4 2020
Q2Q % growth
0.12
50.00%
-0.190.31161.70%
Q3 2020
Q2Q % growth
4.01
1,236.67%
1.262.75218.06%
Q2 2020
Q2Q % growth
-0.02
90.48%
-0.100.0879.94%
Q1 2020
Q2Q % growth
0.44
237.50%
0.050.39723.70%
Q4 2019
Q2Q % growth
0.08 -0.060.14224.77%
Q3 2019
Q2Q % growth
0.30 0.060.24398.93%
Q2 2019
Q2Q % growth
-0.21 -0.12-0.09-79.03%
Q1 2019
Q2Q % growth
-0.32 -0.19-0.13-64.25%
BMRN Yearly EPS VS EstimatesBMRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
747.313M
15.65%
727.71M19.603M2.69%
Q3 2024
Q2Q % growth
745.74M
28.28%
714.18M31.56M4.42%
Q2 2024
Q2Q % growth
712.029M
19.61%
675.29M36.739M5.44%
Q1 2024
Q2Q % growth
648.833M
8.79%
664.82M-15.987M-2.40%
Q4 2023
Q2Q % growth
646.207M
20.22%
649.62M-3.413M-0.53%
Q3 2023
Q2Q % growth
581.329M
15.05%
620.85M-39.521M-6.37%
Q2 2023
Q2Q % growth
595.275M
11.52%
607.14M-11.865M-1.95%
Q1 2023
Q2Q % growth
596.415M
14.83%
582.04M14.375M2.47%
Q4 2022
Q2Q % growth
537.5M
19.50%
547.71M-10.21M-1.86%
Q3 2022
Q2Q % growth
505.3M
23.64%
528.78M-23.48M-4.44%
Q2 2022
Q2Q % growth
533.8M
6.40%
531.9M1.9M0.36%
Q1 2022
Q2Q % growth
519.4M
6.87%
517.67M1.73M0.33%
Q4 2021
Q2Q % growth
449.8M
-0.51%
451.23M-1.43M-0.32%
Q3 2021
Q2Q % growth
408.7M
-14.28%
444.03M-35.33M-7.96%
Q2 2021
Q2Q % growth
501.7M
16.81%
457.47M44.23M9.67%
Q1 2021
Q2Q % growth
486M
-3.21%
455.38M30.62M6.72%
Q4 2020
Q2Q % growth
452.1M
-0.51%
449.03M3.07M0.68%
Q3 2020
Q2Q % growth
476.8M
3.40%
463.74M13.06M2.82%
Q2 2020
Q2Q % growth
429.5M
10.75%
426.99M2.51M0.59%
Q1 2020
Q2Q % growth
502.1M
25.31%
478.15M23.95M5.01%
Q4 2019
Q2Q % growth
454.4M 468.52M-14.12M-3.01%
Q3 2019
Q2Q % growth
461.1M 463.64M-2.54M-0.55%
Q2 2019
Q2Q % growth
387.8M 423.34M-35.54M-8.40%
Q1 2019
Q2Q % growth
400.7M 397.45M3.25M0.82%
BMRN Yearly Revenue VS EstimatesBMRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS10.15% 12.11% 0% 1.45%
Revenue1.52% 2.12% -0.03% 0.22%